Edwards Lifesciences Corporation (EW) Discusses CLASP II TR and PROGRESS Trial Results in Tricuspid and TAVR Transcript

· seekingalpha.com

Edwards Lifesciences Corporation (EW) Discusses CLASP II TR and PROGRESS Trial Results in Tricuspid and TAVR November 2, 2026 8:00 PM ESTCompany...

Conversation

Unknown Executive

All right. Glad everyone could join us today. Thanks so much for coming. If you can make your way to a seat, there are drinks a...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI